Whitney Ijem

Stock Analyst at Canaccord Genuity

(0)
# 4370
Out of 5,336 analysts
106
Total ratings
32.31%
Success rate
-10.89%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ARCT Arcturus Therapeutic...
Maintains: Buy
68 66
11.04 497.83% 6 May 13, 2025
RCKT Rocket Pharmaceutica...
Maintains: Buy
36 34
6.2 448.39% 7 May 12, 2025
RGLS Regulus Therapeutics
Downgrades: Hold
28 11
7.86 39.95% 6 Apr 30, 2025
VERV Verve Therapeutics
Maintains: Strong Buy
32 39
4.3 806.98% 5 Apr 15, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
81 92
55.97 64.37% 7 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
385 390
263.29 48.13% 8 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
0.38 2268.42% 2 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 6
0.38 1478.95% 6 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
39 39
22.37 74.34% 2 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
121 136
34.56 293.52% 8 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Hold
408 424
418.2 1.39% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 90
7.83 1049.43% 5 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
2.35 240.43% 8 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 13
0.28 4542.86% 6 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
36.02 316.44% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
59.02 42.32% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
n/a n/a 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
120 240
4.85 4848.45% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018